Recent IPOs (BK2543) Stock Forum and Discussion

Investment ThemesDetailed Quotes

Recent IPOs Watchlist

377.315
-15.281-3.89%

Close Dec 18 16:00 ET

393.182High376.278Low

Constituent Stocks: 423Top Rising: PLRZ+213.33%

淡定的惠特莫爾

3 minutes ago

MicroStrategy Chairman Michael Saylor Eyes' Intelligent Leverage' With Bitcoin Purchases

$T-Rex 2X Long MSTR Daily Target ETF (MSTU.US)$

103776095

27 minutes ago

$Oriental Rise Holdings (ORIS.US)$ fall againt maybe.

Stock_Drift

37 minutes ago

Pre Market Ticks. 5:38am 12/19

$Gorilla Technology (GRRR.US)$ $Meihua International (MHUA.US)$ $Dragonfly Energy (DFLI.US)$ $Sacks Parente Golf (SPGC.US)$ $KULR Technology (KULR.US)$ $XCHG (XCH.US)$ $Sangamo Therapeutics (SGMO.US)$ $Elevai Labs (ELAB.US)$ $Fitell (FTEL.US)$ $Mesoblast (MESO.US)$ $Silexion Therapeutics (SLXN.US)$ $AppTech Payments (APCX.US)$ $XChange TEC (XHG.US)$ $Currenc Group (CURR.US)$
📊⚡️📊

72321279

51 minutes ago

$SKK Holdings (SKK.US)$ dead volume no chance gor improvement

DrC 504

2 hours ago

$BioAge Labs (BIOA.US)$ What will it take for this stock?

Adam_Flannery

2 hours ago

Question

$Polyrizon (PLRZ.US)$ is this pumping tonightt again?

103845021

3 hours ago

$XCHG (XCH.US)$
careful, market is red !
Dont cry later !

Jaguar8

4 hours ago

BioArctic will receive a USD 100 million upfront payment and up to USD 1.25 billion in milestone payments

$BioAge Labs (BIOA.US)$
Bristol Myers Squibb will become solely responsible for the development and any subsequent commercialization of BAN1503 and BAN2803 and related products worldwide.

Jaguar8

4 hours ago

After Novartis collaboration 12/18, Now global license with Bristol Myers 12/19. One of my top watch. I brought the news before Moomoo again

$BioAge Labs (BIOA.US)$

Jaguar8

4 hours ago

NEWS

$BioAge Labs (BIOA.US)$
BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program
STOCKHOLM, Dec. 19, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that it has entered into a global exclusive license agreement with Bristol Myers Squibb (NYSE: BMY) for BioArctic's PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody program, including BAN1503 and BAN2803, whereof the latter includes BioAr...

No comment yet